(Q30676331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jerome de Seze

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Marco Aurelio Lana-Peixoto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Kazuo Fujihara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

647-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics

27 February 2020

cites work

1 reference

Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

21 January 2018

1 reference

A population-based study of neuromyelitis optica in Caucasians

21 January 2018

1 reference

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

21 January 2018

1 reference

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

21 January 2018

1 reference

Neuromyelitis optica treatment: analysis of 36 patients

21 January 2018

1 reference

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil

21 January 2018

1 reference

Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials

21 January 2018

1 reference

Conventional brain MRI in neuromyelitis optica

21 January 2018

1 reference

An epidemiological study of neuromyelitis optica in Cuba

21 January 2018

1 reference

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

21 January 2018

1 reference

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

An unusual chiasmal visual defect in a patient with neuromyelitis optica: case report

21 January 2018

1 reference

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

21 January 2018

1 reference

Quantifying axonal loss after optic neuritis with optical coherence tomography.

21 January 2018

1 reference

Optical coherence tomography in neuromyelitis optica

21 January 2018

1 reference

Neuropathic pruritus (itch) in neuromyelitis optica

21 January 2018

1 reference

Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis

21 January 2018

1 reference

Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis

21 January 2018

1 reference

Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges.

21 January 2018

1 reference

Microcystic macular oedema in multiple sclerosis is associated with disease severity

21 January 2018

1 reference

Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders

21 January 2018

1 reference

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis.

21 January 2018

1 reference

Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica

21 January 2018

1 reference

"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica

21 January 2018

1 reference

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

21 January 2018

1 reference

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

21 January 2018

1 reference

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica

21 January 2018

1 reference

Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study

21 January 2018

1 reference

Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients

21 January 2018

1 reference

Chronic relapsing inflammatory optic neuropathy (CRION).

21 January 2018

1 reference

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

21 January 2018

1 reference

Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.

21 January 2018

1 reference

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

21 January 2018

1 reference

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity

21 January 2018

1 reference

Influence of pregnancy on neuromyelitis optica spectrum disorder

21 January 2018

1 reference

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

21 January 2018

1 reference

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

21 January 2018

1 reference

Failure of natalizumab to prevent relapses in neuromyelitis optica.

21 January 2018

1 reference

Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica

21 January 2018

1 reference

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

21 January 2018

1 reference

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

Optic neuritis in neuromyelitis optica

21 January 2018

1 reference

Brain magnetic resonance imaging abnormalities in neuromyelitis optica

21 January 2018

1 reference

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

21 January 2018

1 reference

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

Familial neuromyelitis optica.

21 January 2018

1 reference

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

21 January 2018

1 reference

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

Epidemiology of neuromyelitis optica in the United States: a multicenter analysis

21 January 2018

1 reference

Natural history of the visual impairment of relapsing neuromyelitis optica.

21 January 2018

1 reference

Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica

21 January 2018

1 reference

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

21 January 2018

1 reference

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica

21 January 2018

1 reference

Intermittent plasmapheresis prevents recurrence in neuromyelitis optica

21 January 2018

1 reference

Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis

21 January 2018

1 reference

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica

21 January 2018

1 reference

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica

21 January 2018

1 reference

Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis

21 January 2018

1 reference

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.

21 January 2018

1 reference

Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications

21 January 2018

1 reference

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

21 January 2018

1 reference

Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica

21 January 2018

1 reference

Treatment of neuromyelitis optica: an evidence based review

21 January 2018

1 reference

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

21 January 2018

1 reference

Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.

21 January 2018

1 reference

AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

21 January 2018

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

21 January 2018

1 reference

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study

21 January 2018

1 reference

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica

21 January 2018

1 reference

Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis

21 January 2018

1 reference

Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?

21 January 2018

1 reference

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

21 January 2018

1 reference

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

21 January 2018

1 reference

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

The spectrum of neuromyelitis optica

21 January 2018

1 reference

Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder

21 January 2018

1 reference

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

21 January 2018

1 reference

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

21 January 2018

1 reference

Preferential spinal central gray matter involvement in neuromyelitis optica

21 January 2018

1 reference

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels

21 January 2018

1 reference

Neuromyelitis optica without typical opticospinal phenotype

21 January 2018

1 reference

Therapeutic Efficacy of Interferon β-1b in Japanese Patients with Optic-Spinal Multiple Sclerosis

21 January 2018

1 reference

Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody

21 January 2018

1 reference

Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status

21 January 2018

1 reference

HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BPA.12087

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118482%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference